ID: ALA4471291

Max Phase: Preclinical

Molecular Formula: C62H74O22

Molecular Weight: 1171.25

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1c(C)c(OC(=O)c2c(C)c(C)c(OC(=O)c3c(C)c(C(=O)Oc4c(C)c(C)c(C(=O)Oc5c(C)c(C)c(C(=O)OC(OC)OC)c(OC)c5C)c(OC)c4C)c(OC)c(C)c3OC)c(C)c2OC)c(C)c(C)c1C(=O)OC(OC)OC

Standard InChI:  InChI=1S/C62H74O22/c1-25-29(5)47(34(10)49(69-15)39(25)55(63)79-45-31(7)27(3)41(51(71-17)36(45)12)59(67)83-61(75-21)76-22)81-57(65)43-33(9)44(54(74-20)38(14)53(43)73-19)58(66)82-48-30(6)26(2)40(50(70-16)35(48)11)56(64)80-46-32(8)28(4)42(52(72-18)37(46)13)60(68)84-62(77-23)78-24/h61-62H,1-24H3

Standard InChI Key:  DCLKCTSNUKUFFY-UHFFFAOYSA-N

Associated Targets(Human)

Proteasome assembly chaperone 3 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PAC1-PAC2 complex 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1171.25Molecular Weight (Monoisotopic): 1170.4672AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ohsawa K, Yoshida M, Izumikawa M, Takagi M, Shin-Ya K, Goshima N, Hirokawa T, Natsume T, Doi T..  (2018)  Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer.,  26  (23-24): [PMID:30455074] [10.1016/j.bmc.2018.11.001]

Source